Simple guidelines for efficient referral of soft-tissue sarcomas: A population-based evaluation of adherence to guidelines and referral patterns

Journal of Bone and Joint Surgery

Volumn 94, Issue 14, 2012, Pages 1291-1296

  Styring, E ^a   Billing, V ^a   Hartman, L ^a   Nilbert, M ^a   Seinen, J M ^b   Veurink, N ^a   Vult Von Steyern, F ^a   Rydholm, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CANCER SURGERY; FEMALE; FIBROSARCOMA; GENERAL PRACTITIONER; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SWEDEN; SYNOVIAL SARCOMA;

EID: 84864119827     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.01271     Document Type: Article

References (32)

1. Myhre-Jensen O. A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand. 1981 Jun;52(3):287-93. (Pubitemid 11049185)
2. Rydholm A, Berg NO, Persson BM, Akerman M. Treatment of soft-tissue sarcoma should be centralised. Acta Orthop Scand. 1983 Jun;54(3):333-9. (Pubitemid 13053479)
3. Abellan JF, Lamo de Espinosa JM, Duart J, Patiño-García A, Martin-Algarra S, Martínez-Monge R, San-JulianM. Nonreferral of possible soft tissue sarcomas in adults: a dangerous omission in policy. Sarcoma. 2009;2009:827912. Epub 2009 Dec 31.
4. Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br. 2008 Feb;90(2):203-8. (Pubitemid 351303348)
5. Glencross J, Balasubramanian SP, Bacon J, Robinson MH, Reed MW. An audit of the management of soft tissue sarcoma within a health region in the UK. Eur J Surg Oncol. 2003 Oct;29(8):670-5. (Pubitemid 37236289)
6. Johnson GD, Smith G, Dramis A, Grimer RJ. Delays in referral of soft tissue sarcomas. Sarcoma. 2008;2008:378574.
7. Bauer HC, Trovik CS, Alvegård TA, Berlin O, Erlanson M, Gustafson P, Klepp R, Möller TR, Rydholm A, Saeter G, Wahlström O, Wiklund T. Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2001 Apr;72(2):150-9. (Pubitemid 32405276)
8. Bhangu AA, Beard JA, Grimer RJ. Should soft tissue sarcomas be treated at a specialist centre?. Sarcoma. 2004;8(1):1-6. (Pubitemid 38429255)
9. Potter BK, Adams SC, Pitcher JD Jr, Temple HT. Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res. 2008 Dec;466(12):3093-100. Epub 2008 Sep 26.
10. Gustafson P, Dreinhöfer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand. 1994 Feb;65(1):47-50. (Pubitemid 24101911)
11. Clasby R, Tilling K, Smith MA, Fletcher CD. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg. 1997 Dec;84(12):1692-6. (Pubitemid 27519597)
12. Brouns F, Stas M, De Wever I. Delay in diagnosis of soft tissue sarcomas. Eur J Surg Oncol. 2003 Jun;29(5):440-5. (Pubitemid 36748587)
13. Clarkson P, Ferguson PC. Primary multidisciplinary management of extremity soft tissue sarcomas. Curr Treat Options Oncol. 2004 Dec;5(6):451-62. (Pubitemid 39591805)
14. Scandinavian Sarcoma Group. Centralized registration of sarcoma patients in Scandinavia, SSG VII. http://www.ssg-org.net/treatment-protocols-and- recommendations/ongoing. Accessed 2011 Aug 11.
15. Rydholm A. Management of patients with soft-tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand Suppl. 1983;203:13-77.
16. Rydholm A, Berg NO, Gullberg B, Thorngren KG, Persson BM. Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the inter-relationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):363-74. (Pubitemid 15216832)
17. Boden RA, Clark MA, Neuhaus SJ, A'hern JR, Thomas JM, Hayes AJ. Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol. 2006 Dec;32(10):1154-8. Epub 2006 Jul 25.
18. Jansen-Landheer ML, Krijnen P, Oostindiër MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, Steup WH, Taminiau AH, Vree R, Hogendoorn PC, Tollenaar RA, Gelderblom H. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study. Eur J Surg Oncol. 2009 Dec;35(12):1326-32. Epub 2009 Jun 13.
19. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patientswithmalignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982 Oct;64(8):1121-7. (Pubitemid 13244005)
20. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996 May;78(5):656-63.
21. Nijhuis PH, Schaapveld M, Otter R, Hoekstra HJ. Soft tissue sarcoma-compliance with guidelines. Cancer. 2001 Jun 1;91(11):2186-95.
22. Palesty JA, Kraybill WG. Developments in the management of extremity soft tissue sarcomas. Cancer Invest. 2005;23(8):692-9. (Pubitemid 43041716)
23. Ray-Coquard I, Thiesse P, Ranchère-Vince D, Chauvin F, Bobin JY, Sunyach MP, Carret JP, Mongodin B, Marec-Bérard P, Philip T, Blay JY. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004 Feb;15(2):307-15. (Pubitemid 38262633)
24. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
25. Pérez Romasanta LA, Montero Luis A, Verges Capdevila R, Mariño Cotelo A, Rico Pérez JM; SEOR Sarcoma Group. Centralised treatment of soft tissue sarcomas in adults. Clin Transl Oncol. 2008 Feb;10(2):102-10.
26. Persson BM, Rydholm A. Soft-tissue masses of the locomotor system. A guide to the clinical diagnosis of malignancy. Acta Orthop Scand. 1986 Jun; 57(3):216-9. (Pubitemid 16040841)
27. Rööser B, Rydholm A, Alvegård T. Centralization of soft tissue sarcoma. Status in Sweden in 1982. Acta Orthop Scand. 1987 Dec;58(6):641-4.
28. Domanski HA, Akerman M, Carlén B, Engellau J, Gustafson P, Jonsson K, Mertens F, Rydholm A. Core-needle biopsy performed by the cytopathologist: a technique to complement fine-needle aspiration of soft tissue and bone lesions. Cancer. 2005 Aug 25;105(4):229-39. (Pubitemid 41177003)
29. Cooper TM, Sheehan M, Collins D, O'Connor TP. Soft tissue sarcoma of the extremity. Ann R Coll Surg Engl. 1996 Sep;78(5):453-6. (Pubitemid 26320784)
30. Nijhuis PH, Schaapveld M, Otter R, Molenaar WM, van der Graaf WT, Hoekstra HJ. Epidemiological aspects of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials. Eur J Cancer. 1999 Nov;35(12):1705-10. (Pubitemid 30050644)
31. Pencavel TD, Strauss DC, Thomas GP, Thomas JM, Hayes AJ. Does the twoweek rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre. Ann R Coll Surg Engl. 2010 Jul;92(5):417-21. Epub 2010 May 19.
32. Malik A, Wigney L, Murray S, Gerrand CH. The effectiveness of "two-week" referrals for suspected bone and soft tissue sarcoma. Sarcoma. 2007;2007:23870.